Age-Stratified Phase I Trial of a Combination of Bortezomib, Gemcitabine, and Liposomal Doxorubicin in Patients With Advanced Malignancies
Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-011-1808-4
Full Text
Open PDFAbstract
Available in full text
Date
December 29, 2011
Authors
Publisher
Springer Science and Business Media LLC